Glenmark Pharmaceuticals Inc., USA 2026-01-07 Health serious FDA
Health · FDA · Recall #FDA-D-0246-2026
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each… Recall
Issued January 7, 2026 · Glenmark Pharmaceuticals Inc., USA
In January 2026, Glenmark Pharmaceuticals Inc., USA recalled the Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
What you should do
- 1 Stop using Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Glenmark Pharmaceuticals Inc., USA to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Glenmark Pharmaceuticals Inc., USA
- Category
- Health
- Recall date
- January 7, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0246-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Glenmark Pharmaceuticals Inc., USA has 53 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.